ProMIS Neurosciences to Present Data at 2019 Alzheimer’s Association International Conference

ProMIS Neurosciences to Present Data at 2019 Alzheimer’s Association International Conference Abstracts selected for oral and poster presentation  TORONTO and CAMBRIDGE, MA, July 10, 2019 /CNW/ – ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, … Continue reading ProMIS Neurosciences to Present Data at 2019 Alzheimer’s Association International Conference

Spectrum Therapeutics partners with Canadian Mental Health Association’s Not Myself Today® initiative

Spectrum Therapeutics partners with Canadian Mental Health Association’s Not Myself Today® initiative SMITHS FALLS, ON and TORONTO, July 10, 2019 /CNW/ – Spectrum Therapeutics (“Spectrum”), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the “Company” or “Canopy Growth”) is pleased to announce a partnership with the Canadian Mental Health Association (“CMHA”). The initiative, … Continue reading Spectrum Therapeutics partners with Canadian Mental Health Association’s Not Myself Today® initiative

Numbering You Won’t Stop the Opioid Crisis

Numbering You Won’t Stop the Opioid Crisis by: Jane M. Orient, M.D. People are dying all over the country from opioid overdoses. There’s a movement to have the antidote naloxoneavailable in all ambulances and even over the counter. This temporarily reverses the fatal effect of opioids, which stop the patient’s breathing. First responders themselves may need … Continue reading Numbering You Won’t Stop the Opioid Crisis

Newron’s commercialization partner Zambon and Valeo Pharma announce the launch of Onstryv® (safinamide) for Parkinson’s disease in Canada

Newron’s commercialization partner Zambon and Valeo Pharma announce the launch of Onstryv® (safinamide) for Parkinson’s disease in Canada  Milan, Italy and Montreal, Quebec – July 10, 2019 – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5.XE), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous … Continue reading Newron’s commercialization partner Zambon and Valeo Pharma announce the launch of Onstryv® (safinamide) for Parkinson’s disease in Canada

New Committee Brings Diverse Patient, Family, and Caregiver Voices to CADTH

New Committee Brings Diverse Patient, Family, and Caregiver Voices to CADTH OTTAWA, July 10, 2019 /CNW/ – Following a nationwide call for nominations, CADTH is pleased to announce the membership of its new Patient and Community Advisory Committee.  Twelve individuals from across the country have been invited to join the committee as inaugural members. Committee members … Continue reading New Committee Brings Diverse Patient, Family, and Caregiver Voices to CADTH